Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Disclosed planOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 6 of the 13 calendar months from Oct 2025 to Oct 2026: Oct 2025, Dec 2025, Feb 2026, Apr 2026, Jul 2026 and Oct 2026.
- Largest single sale: $8.9M (100,000 shares) of Kymera Therapeutics, Inc. on Dec 8, 2025. Filing
- Last sale before this period: Sep 16, 2025.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Kymera Therapeutics, Inc. (KYMR) | Chief Executive Officer, Director | Aug 20, 2020 | Oct 1, 2026 |
Recent filings
The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Oct 1, 2026, Kymera Therapeutics, Inc.: sold 30,000 shares for $3.4M, under a disclosed plan; 30,000 shares acquired by exercising options. 1 filing: 1
- Jul 7, 2026, Kymera Therapeutics, Inc.: sold 50,000 shares for $6.0M, under a disclosed plan; 50,000 shares acquired by exercising options. 1 filing: 1
- Jul 1, 2026, Kymera Therapeutics, Inc.: sold 80,000 shares for $9.2M, under a disclosed plan; 80,000 shares acquired by exercising options. 1 filing: 1
- Apr 29, 2026, Kymera Therapeutics, Inc.: sold 30,000 shares for $2.4M, under a disclosed plan; 30,000 shares acquired by exercising options. 1 filing: 1
- Feb 25, 2026, Kymera Therapeutics, Inc.: sold 30,000 shares for $2.7M, under a disclosed plan; 30,000 shares acquired by exercising options. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.